IVERIC bio, Inc. Announces Closing of Public Offering and Concurrent Private Placement with $160 Million in Gross Proceeds
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. announced the closing of public offering and concurrent private placement with $160 million in gross proceeds.